Hemoglobin News and Research

RSS
XOMA completes patient enrollment in XOMA 052 Phase 2a trial

XOMA completes patient enrollment in XOMA 052 Phase 2a trial

OrSense introduces NBM200 system for anemia screening, hemorrhage detection

OrSense introduces NBM200 system for anemia screening, hemorrhage detection

Phase 3 clinical study demonstrates efficacy of metformin therapy in type 2 diabetes

Phase 3 clinical study demonstrates efficacy of metformin therapy in type 2 diabetes

Boehringer Ingelheim to present linagliptin Phase III data at 46th EASD

Boehringer Ingelheim to present linagliptin Phase III data at 46th EASD

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

FG-4592 oral anemia therapy receives CTA approval from SFDA

FG-4592 oral anemia therapy receives CTA approval from SFDA

Dapagliflozin added to glimepiride therapy reduces HbA1c in adult type 2 diabetes patients

Dapagliflozin added to glimepiride therapy reduces HbA1c in adult type 2 diabetes patients

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

Dartmouth study says primary care not always a cure-all

Dartmouth study says primary care not always a cure-all

Researchers find risk prediction model for VTE in cancer patients

Researchers find risk prediction model for VTE in cancer patients

Iron supplements reduce risk of iron deficiency and anemia in children with marginally low birth weights

Iron supplements reduce risk of iron deficiency and anemia in children with marginally low birth weights

NYBC calls for blood donations as Hurricane Earl approaches

NYBC calls for blood donations as Hurricane Earl approaches

Avoidance of fluoride reduces anemia in pregnant women and decreases pre-term births

Avoidance of fluoride reduces anemia in pregnant women and decreases pre-term births

Sangart reports positive MP4OX Phase IIa study data in severely injured trauma patients with hemorrhagic shock

Sangart reports positive MP4OX Phase IIa study data in severely injured trauma patients with hemorrhagic shock

Sangart reports positive data from MP4OX Phase IIa study in trauma patients

Sangart reports positive data from MP4OX Phase IIa study in trauma patients

National Association of Free Clinic available to uninsured residents in New Orleans

National Association of Free Clinic available to uninsured residents in New Orleans

Study finds sexual problem common among diabetic patients

Study finds sexual problem common among diabetic patients

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

NYBC calls for blood donation in remembrance of 9/11 victims

NYBC calls for blood donation in remembrance of 9/11 victims

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.